STAT

A rhyming year in review: Limericks that capture the best and worst of life sciences in 2017

There once was a poet from STAT/Who pulled fun rhymes out of a hat/Her limericks made us laugh/And her every paragraph/Is a gift we hope doesn't fall flat.

We’re big fans of the offbeat here at STAT. So what better way to round out the last days of 2017 than to bring you the year in review — in rhyme? Without further ado, to see last year’s offerings.) 

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min read
STAT+: Senate Drug Shortage Bill Would Pay Hospitals Bonuses For Good Contracting Practices
A bipartisan Senate bill takes a new approach to persistent drug shortages: have Medicare pay bonuses to hospitals and physicians for contracting that ensures a steady supply.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About GLP-1 Spending, Biosimilar Patient Costs, And More
Spending on GLP-1 drugs like Ozempic and Wegovy ballooned last year and they're set to cost the U.S. health care system and the federal government still more.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About FTC Fighting ‘Junk’ Patents, Pfizer Direct-to-consumer Plans, And More
The FTC expanded its campaign against pharmaceutical companies for filing what it calls “junk” patent listings for 20 different brand-name treatments.

Related Books & Audiobooks